Tweets
@ashira_md blazing through again! Tune in now to hear her talk on #microaggressions and #gaslighting
#ACR21 #ACRAmbassador #DEI https://t.co/uqvLxxcs43
Vaneet K Sandhu, MD (she/her/hers) @vksandhumd ( View Tweet )
4 years 8 months ago
🆕 Main findings of #Lupus trials presented at #ACR21 ⬇️ https://t.co/HENxcyLuf5
Laurent ARNAUD @Lupusreference ( View Tweet )
4 years 8 months ago
🗳️Poll of the day for #ACR21 #ACRambassador
@ACRheum
🤔What format do you prefer for #ACR22?
Herman Tam @DrPedsRheum ( View Tweet )
4 years 8 months ago
Dr. Lane on Ca/Vitamin D in Osteoporosis
⭐️🎯serum vitamin D 25OH ~38
⭐️Studies since 2008 Auckland Calcium trial DO NOT support incr CV risk with Ca supplementation
⭐️Ca calculator: https://t.co/PLPMfZdIwb
⭐️No sig change in fracture risk with supp
#ACR21 #ACRAmbassador https://t.co/KUa52vf4gT
Veena Katikineni @VeenaRheumMD ( View Tweet )
4 years 8 months ago
Dr. Fiorentino on cancer risk stratification and screening in myositis. Come chat at noon in the Myositis Community Hub to learn more!
#ACR21 #ACRAmbassador https://t.co/I0iQuPAuOl
Veena Katikineni @VeenaRheumMD ( View Tweet )
4 years 8 months ago
Thanks Dr David Fiorentino for his talk on CA and myositis!
⬆️risk:
- DM
- >45-50yo
- males
- TIF1-gamma Ab (4.7RR of CA)
- NXP2
- low CK
- dysphagia
⬇️ risk:
- synthetase Ab
- raynaud
- ILD
- inflamm arth
🚨TIF1-gamma🚨
- ovarian CA (older, IgG2)
#ACR21 #ACRAmbassador
Vaneet K Sandhu, MD (she/her/hers) @vksandhumd ( View Tweet )
4 years 8 months ago
Risk Stratification for CA in IIM
Low risk:
- no clin RF + at least 1 protective factor
- autoAb (Jo1, Mi2, MDA5,SRP,RNP/SSA/SSB)
Intmdt risk:
- 1-2 clin RF
- auto Ab (SAE1, HMGCR)
- PM/INMN no Ab
Hi riks:
- >2 clin RF
- h/o CA
- autoAb (TIF1g, NXP2)
#ACR21 #ACRAmbassador https://t.co/nTBSDcS1v4
Vaneet K Sandhu, MD (she/her/hers) @vksandhumd ( View Tweet )
4 years 8 months ago
Screening for CA in IIM:
Low risk:
* CXR, age approp CA screen
Intmdt risk:
* CT c/a/p, tm mrkrs (CA125♀️, PSA♂️), pelvic US, colo <50yo, mammo <50>75)
Hi risk (?annually):
* whole body PET-CT
When?
Annual x hi risk?
Recalcitrant /Unexpl flare
#ACR21 #ACRAmbassador
Vaneet K Sandhu, MD (she/her/hers) @vksandhumd ( View Tweet )
4 years 8 months ago
#ACR21 #pedsrheum
I say it counts!
I mean, at the end of the day, these are all just pictures of food on the internet, right?
#ACRBakeAnythingChallenge https://t.co/bVQuealWWX
Dr. Laura Lewandowski @LauraLewMad11 ( View Tweet )
4 years 8 months ago
Dr. Melissa Munroe - Lupus Classification Risk Immune Index
🔹Pre-/post-classification serum
🔹Avg time➡️classification 4.7y
🔹9 immune mediators altered in pre-clinical dz
🔹Pos score = ⬆️likelihood➡️SLE; Neg = ⬇️
https://t.co/UFEkGieXum
1/2
#ACR21 Abst#1423 @RheumNow #ACRBest
Pedro Castillo @_Castillo_Pedro ( View Tweet )
4 years 8 months ago
Late breaking, but just in time! mRNA COVID-19 3rd dose in RTX pts, w/o Ab response post initial series. After 3rd dose many had ab response or T cell response.
Extra vaccine full doses can protect RTX pts from COVID! AbsL17 #ACRbest #ACR21 @RheumNow https://t.co/lIDPzybmT7 https://t.co/jEJ3N6cdjK
Dr. Rachel Tate @uptoTate ( View Tweet )
4 years 8 months ago
Important late breaker @TerrierBen, DBRCT of RTX vs GC (FFS=0) or CYC (FFS>0) for EGPA
RTX not superior to CYC (64% RTX vs 60% CYC BVAS remission d180, p = 0.745); similar in subgroups
Feel like this lends support to (~surprising) ACR/VF recs for EGPA?
#ACR21 #ACRAmbassador https://t.co/gpsPtXF6pj
Mike Putman @EBRheum ( View Tweet )
4 years 8 months ago
